Hanall Biopharma Co., Ltd. (KRX: 009420)

Hanall Biopharma Revenue

Hanall Biopharma had revenue of 31.59B KRW in the quarter ending June 30, 2024, a decrease of -23.72%. This brings the company's revenue in the last twelve months to 130.37B, up 0.30% year-over-year. In the year 2023, Hanall Biopharma had annual revenue of 134.91B with 22.65% growth.

• Revenue (ttm): 130.37B
• Revenue Growth: +0.30%
• P/S Ratio: 15.88
• Revenue / Employee: 426.06M
• Employees: 306
• Market Cap: 2,073.99B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	134.91B	24.91B	22.65%
Dec 31, 2022	110.00B	8.40B	8.27%
Dec 31, 2021	101.59B	12.99B	14.66%
Dec 31, 2020	88.60B	-19.85B	-18.30%
Dec 31, 2019	108.45B	16.61B	18.09%